Tandem Diabetes Care target price cut to $28 from $31
TNDM•Truist Securities cut its target price for Tandem Diabetes Care to $28 from $31.
Related News
Zoetis schedules webcast, conference call on third-quarter results
ZTS•
Everpure Inc: Needham raises target price to $150 from $140
P•
Veeva to present clinical data solutions at R&D and Quality Summit
VEEV•
Yum Brands: Argus Research cuts to hold from buy
YUM•
Merck's eye disease drug meets main goal in trial
MRK•